ATE437955T1 - Modulation der produktion von kapsel- polysacchariden aus pneumokokken - Google Patents

Modulation der produktion von kapsel- polysacchariden aus pneumokokken

Info

Publication number
ATE437955T1
ATE437955T1 AT01918754T AT01918754T ATE437955T1 AT E437955 T1 ATE437955 T1 AT E437955T1 AT 01918754 T AT01918754 T AT 01918754T AT 01918754 T AT01918754 T AT 01918754T AT E437955 T1 ATE437955 T1 AT E437955T1
Authority
AT
Austria
Prior art keywords
pneumococces
modulation
production
test compound
capsule polysaccharides
Prior art date
Application number
AT01918754T
Other languages
English (en)
Inventor
Jeffrey Weiser
Original Assignee
Philadelphia Children Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22699002&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE437955(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Philadelphia Children Hospital filed Critical Philadelphia Children Hospital
Application granted granted Critical
Publication of ATE437955T1 publication Critical patent/ATE437955T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT01918754T 2000-03-16 2001-03-16 Modulation der produktion von kapsel- polysacchariden aus pneumokokken ATE437955T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18984700P 2000-03-16 2000-03-16
PCT/US2001/008442 WO2001068903A1 (en) 2000-03-16 2001-03-16 Modulating production of pneumococcal capsular polysaccharide

Publications (1)

Publication Number Publication Date
ATE437955T1 true ATE437955T1 (de) 2009-08-15

Family

ID=22699002

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01918754T ATE437955T1 (de) 2000-03-16 2001-03-16 Modulation der produktion von kapsel- polysacchariden aus pneumokokken

Country Status (18)

Country Link
US (1) US6642017B2 (de)
EP (2) EP1967591A3 (de)
JP (1) JP4856345B2 (de)
KR (3) KR100914702B1 (de)
CN (2) CN100529054C (de)
AT (1) ATE437955T1 (de)
AU (2) AU2001245795B2 (de)
BR (1) BRPI0109293B8 (de)
CA (1) CA2403001C (de)
CY (1) CY1109418T1 (de)
DE (1) DE60139384D1 (de)
DK (1) DK1268844T3 (de)
ES (1) ES2330919T3 (de)
IL (3) IL151772A0 (de)
MX (1) MXPA02009047A (de)
NZ (1) NZ521343A (de)
PT (1) PT1268844E (de)
WO (1) WO2001068903A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001245795B2 (en) * 2000-03-16 2005-07-28 The Children's Hospital Of Philadelphia Modulating production of pneumococcal capsular polysaccharide
US7709001B2 (en) * 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
CN101155833B (zh) * 2005-04-08 2011-04-20 惠氏公司 通过pH操作将污染物与肺炎链球菌多糖分离
US7491517B2 (en) * 2006-07-19 2009-02-17 Jeeri R Reddy Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135
DK2074221T3 (da) * 2006-10-10 2010-09-06 Wyeth Llc Forbedrede fremgangsmåder til separation af streptococcus pneumoniae type 3 polysakkarider
WO2009059054A2 (en) * 2007-10-30 2009-05-07 The Trustees Of The University Of Pennsylvania Bacteria strains an d bacteriocin produced therefrom
ES2749952T3 (es) * 2008-12-18 2020-03-24 Wyeth Llc Procedimiento de control del peso molecular de polisacáridos de Streptococcus pneumoniae usando carbono
BRPI0922981A8 (pt) * 2008-12-18 2019-11-26 Wyeth Llc método para o controle do peso molecular polissacarídeo para o sorotipo 19a de streptococcus pneumoniae
CN102093963B (zh) * 2010-11-26 2012-11-14 兰州生物制品研究所有限责任公司 富含磷壁酸的肺炎链球菌的培养方法
BE1022780B1 (fr) * 2014-05-07 2016-09-02 Glaxosmithkline Biologicals S.A. Purification des polysaccharides secretes par s. agalactiae
US10611664B2 (en) 2014-07-31 2020-04-07 Corning Incorporated Thermally strengthened architectural glass and related systems and methods
US11097974B2 (en) 2014-07-31 2021-08-24 Corning Incorporated Thermally strengthened consumer electronic glass and related systems and methods
CA2956929A1 (en) 2014-07-31 2016-02-04 Corning Incorporated Thermally tempered glass and methods and apparatuses for thermal tempering of glass
US12338159B2 (en) 2015-07-30 2025-06-24 Corning Incorporated Thermally strengthened consumer electronic glass and related systems and methods
KR102492060B1 (ko) 2016-01-12 2023-01-26 코닝 인코포레이티드 얇은, 열적 및 화학적으로 강화된 유리-계 제품
US11795102B2 (en) 2016-01-26 2023-10-24 Corning Incorporated Non-contact coated glass and related coating system and method
WO2019040818A2 (en) 2017-08-24 2019-02-28 Corning Incorporated GLASSES HAVING ENHANCED TEMPERATURE CAPABILITIES
TWI785156B (zh) 2017-11-30 2022-12-01 美商康寧公司 具有高熱膨脹係數及對於熱回火之優先破裂行為的非離子交換玻璃
US20210062138A1 (en) * 2018-01-22 2021-03-04 The Research Foundation For Microbial Diseases Of Osaka University Medium for culturing pneumococcal samples
CN113727954A (zh) 2019-04-23 2021-11-30 康宁股份有限公司 具有确定的应力分布曲线的玻璃层叠物及其制作方法
US11697617B2 (en) 2019-08-06 2023-07-11 Corning Incorporated Glass laminate with buried stress spikes to arrest cracks and methods of making the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510606A1 (fr) * 1981-07-30 1983-02-04 Berri Balzac Procede d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application a la preparation de vaccins
CA2116261A1 (en) * 1993-04-20 1994-10-21 David E. Briles Epitopic regions of pneumococcal surface protein a
WO1995031548A1 (en) * 1994-05-16 1995-11-23 The Uab Research Foundation Streptococcus pneumoniae capsular polysaccharide genes and flanking regions
AU2001245795B2 (en) * 2000-03-16 2005-07-28 The Children's Hospital Of Philadelphia Modulating production of pneumococcal capsular polysaccharide

Also Published As

Publication number Publication date
HK1055448A1 (zh) 2004-01-09
NZ521343A (en) 2005-03-24
CN101586143A (zh) 2009-11-25
KR20080036656A (ko) 2008-04-28
AU2001245795B2 (en) 2005-07-28
WO2001068903A1 (en) 2001-09-20
CY1109418T1 (el) 2014-08-13
IL191962A (en) 2010-12-30
MXPA02009047A (es) 2005-04-19
IL151772A (en) 2009-12-24
PT1268844E (pt) 2009-11-03
KR20030040196A (ko) 2003-05-22
IL151772A0 (en) 2003-04-10
IL191962A0 (en) 2008-12-29
CN100529054C (zh) 2009-08-19
JP4856345B2 (ja) 2012-01-18
JP2003531584A (ja) 2003-10-28
KR100942738B1 (ko) 2010-02-17
EP1268844B1 (de) 2009-07-29
EP1268844A1 (de) 2003-01-02
EP1967591A3 (de) 2008-12-03
US6642017B2 (en) 2003-11-04
CA2403001C (en) 2012-07-03
DK1268844T3 (da) 2009-11-16
EP1967591A2 (de) 2008-09-10
ES2330919T3 (es) 2009-12-17
DE60139384D1 (de) 2009-09-10
CA2403001A1 (en) 2001-09-20
AU4579501A (en) 2001-09-24
US20030021811A1 (en) 2003-01-30
KR100914702B1 (ko) 2009-08-28
EP1268844A4 (de) 2006-03-29
KR20080081978A (ko) 2008-09-10
BRPI0109293B1 (pt) 2015-05-19
BR0109293A (pt) 2003-06-10
CN1429276A (zh) 2003-07-09
BRPI0109293B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
ATE437955T1 (de) Modulation der produktion von kapsel- polysacchariden aus pneumokokken
EA200000457A1 (ru) Способ и система для обнаружения аналита
ATE230923T1 (de) Verfahren und zusammensetzungen zur herstellung getrockneter, lagerungsstabiler blutplättchen
NO20015096L (no) Måling og bruk av molekul¶re interaksjoner
DE69523409D1 (de) Herstellung von Lötverbindungen zur Verwendung in der Verpackung von elektrischen Schaltungen
TR200003632T2 (tr) Benzotiyepin-1,1-dioksid türevleri, üretim yöntemi, bunları içeren ilaçlar.
NO950178L (no) Injeksjon og injeksjonssett
ATE390629T1 (de) Mikrophysiomessgerät
DE60123868D1 (de) Steckverbinder für Kassette von elektronischen Teilen
WO2002009868A3 (en) Apparatus for generating a temperature gradient and methods for using the gradient to characterize molecular interactions
NO880542D0 (no) Zirkoniumchelater og fremstilling og anvendelse av disse.
TR26119A (tr) Hidrojenle zenginlestirilmis bir gazin imalat metodu.
ATE314631T1 (de) Thermometer
BG40148A3 (bg) Метод за получаване на хетероциклично съединение
DE68929371D1 (de) Verstärker mit grosser verstärkung für integrierte schaltungen
ATE491189T1 (de) Chipkarte und verfahren zum schützen einer chipkarte
ES2145510T3 (es) Disoluciones de hidroxilamina estabilizadas.
ATE198208T1 (de) Aus imidazo-(1,5a)-pyridin stammende inhibitoren von serinproteasen
GR900100356A (el) Νέα παράγωγα 9α-υδροξυ-3-οξο4,24(25)-στιγμασταδιέν-26-οϊκού οξέος και μέ?οδος για την παρασκευή τους.
DE60103061D1 (de) Verfahren zur identifizierung von verbindungen, die den anaphase-fördernden komplex hemmen
GR1000359B (el) Μεθοδος παρασκευης 2-μεθοξυκαρβονυλο-υποκατεστημενων ν,ν-δι-(τριmεθοξυβενζουλ) πιπεραζινων.
BG105780A (bg) Метод за производство на деривати на дифенил-2-карбонова киселина
DE3774947D1 (de) Alpha-acylamino-aminoalkyl-phosphonat-inhibitor des angiotensin umwandelnden enzyms.
NO912002D0 (no) Homogene hoeytemperatursupraledere og fremgangsmaate for fremstilling av disse.
NO900799D0 (no) Fremgangsmaate for fremstilling av inhibitorer for angiotensinomdannende enzym.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1268844

Country of ref document: EP